Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of soluble B cell maturation antigen as a biomarker in multiple myeloma

25 Oct 2022

Abstract excerpt

Currently used stratification models in myeloma precursor disease as well as staging systems and response criteria in myeloma have limitations including failure to identify functionally high-risk myeloma patients. B-cell maturation antigen, a transmembrane glycoprotein required for long-lived plasma cells, is specific and expressed by myeloma cells. When it sheds from the surface of myeloma cells it can be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Peptidase Inhibition and Analysis
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36282671
DOI: 10.1080/10428194.2022.2133540

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of soluble B cell maturation antigen as a biomarker in multiple myelomaPMID 36282671Read ↗

Non-secretory multiple myeloma: from biology to clinical managementSemantic proximity Read ↗

Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice.Semantic proximity Read ↗

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapySemantic proximity Read ↗

Challenges, Difficulties, and Delayed Diagnosis of Multiple MyelomaSemantic proximity Read ↗

Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma.Semantic proximity Read ↗

Myeloma phenotype: clues to disease origin and manifestation.Semantic proximity Read ↗

Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistanceSemantic proximity Read ↗

Extracellular Vesicles in Multiple Myeloma—Cracking the Code to a Better Understanding of the DiseaseSemantic proximity Read ↗

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment.Semantic proximity Read ↗

CAR T-cell therapy in multiple myeloma: mission accomplished?Semantic proximity Read ↗

Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.Semantic proximity Read ↗

The myeloma stem cell concept, revisited: from phenomenology to operational terms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.